Japanese Encephalitis Vaccine SA14-14-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Japanese Encephalitis Vaccine SA14-14-2, covering 2019-04-26 to 2019-04-26. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2 [Phase 4]